Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
aggrenox
aneurysm, intracranial
anticoagulant, complications of
anticoagulant, treatment
anticoagulant, treatment in CVD
aspirin
aspirin, dose of
aspirin, failure of
basilar artery stenosis
carotid artery stenosis
carotid artery stenosis, intracranial
CAT scan
CAT scan, abnormal
cerebral atherosclerosis
cerebrovascular accident
cerebrovascular accident, prevention of
cerebrovascular accident, recurrent
cerebrovascular accident, severity
cerebrovascular accident, women
cerebrovascular disease
cerebrovascular disease, treatment of
clopidogrel
complications
controversies in neurology
coronary artery disease
coumarin
dipyridamole
endarterectomy, carotid
headache
headache, drug induced
heparin
hyperlipidemia
hypertension
INR values
intracerebral hemorrhage
middle cerebral artery, stenosis of
migraine
mortality
neurologic practice
PFA-100
platelet function test
platelet inhibiting drugs
platelet inhibiting drugs, selection
prevention of neurologic disorders
review article
risk factors
risk-benefit assessment
safety
subarachnoid hemorrhage
ticlopidine
transient ischemic attack
transient ischemic attack, treatment of
treatment of neurologic disorder
vertebral artery stenosis
WASID trial
Showing articles 0 to 50 of 487 Next >>

Low-Dose Aspirin and Risk of Intracranial Bleeds
Neurol 89:2280-2287, Soriano, L.C.,et al, 2017

The Use of Platelet Function Assays May Help to Determine Appropriate Antiplatelet Treatment Options in a Patient With Recurrent Stroke on Baby Aspirin: Against
Stroke 41:2398-2399, 2400, Eikelboom,J.W.,et al, 2010

Platelet Function Assays in Stroke Management: More Study is Needed
Stroke 41:2396-2397, 2400, Selim,M.H.,et al, 2010

Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
NEJM 352:1305-1316, 1368, Chimowitz,M.I.,et al, 2005

10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003

Update on Antiplatelet Therapy for Stroke Prevention
Arch Int Med 160:1579-1582, Sacco,R.L.& Elkind,M.S., 2000

Aspirin for the Primary Prevention of Stroke and Other Major Vascular Events
ArchNeurol 57:326-332,306, Hart,R.G.,et al, 2000

Antiplatelet Therapy:Views from the Experts
Neurol 53:S32-S37, Easton,J.D.,et al, 1999

A Metaregression Analysis of the Dose-Response Effect of Aspirin on Stroke
Arch Int Med 159:1248-1253, Johnson,E.S.,et al, 1999

Low-Dose and High-Dose Acetylsalicylic Acid for Patients Undergoing Carotid Endarterectomy:A Randomised Controlled Trial
Lancet 353:2179-2184,2172, Taylor,D.W.,et al, 1999

Prospective Study of Aspirin Use and Risk of Stroke in Women
Stroke 30:1764-1771, Iso,H.,et al, 1999

Antiplatelet Treatment Does Not Reduce the Severity of Subsequent Stroke
Neurol 53:825-829, Sivenius,J.,et al, 1999

Aspirin in Ischemic Cerebrovascular Disease-How Strong is the Case for a Different Dosing Regimen
Stroke 27:756-760, Patrono,C.&Roth,G.J., 1996

Aspirin Wars-The Optimal Dose of Aspirin to Prevent Stroke
Stroke 27:585-587, Hart,R.G.&Harrison,M.J.G., 1996

Aspirin Dose in Stroke Prevention-Beautiful Hypotheses Slain by Ugly Facts
Stroke 27:588-592, Barnett,H.J.M.,et al, 1996

Failure of Aspirin Treatment After Stroke
Stroke 25:275-277, Bornstein,N.M.,et al, 1994

A Follow-up Survey of Clinical Practices for the Use of Heparin, Warafarin, & Aspirin
Neurol 44:618-621, Alberts,M.J.,et al, 1994

Does Low-Dose ASA Prevent Stroke After Carotid Surgery? A Double-blind, Placebo-controlled Randomized Trial
Stroke 24:1125-1128, Lindblad,B.,et al, 1993

Effects of Low-to-High Doses of Aspirin on Platelet Aggregab & Metabol of Thromboxane A2 & Prostacyclin
Stroke 23:1400-1403, Tohgi,H.,et al, 1992

Low-Dose Aspirin and Stroke"It Ain't Necessarily So"
Stroke 23:1395-1399, Dyken,M.L.,et al, 1992

A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg/day) in Pats. After a TIA or Minor Ischemic Stroke
Dutch TIA Trial Study Group, NEJM 325:1261-1266, 1303991., , 1991

Swedish Aspirin Low-Dose Trial (SALT) of 75 mg Aspirin as Secondary Prophylaxis After Cerebrovascular Ischaemic Events
The SALT Coll Group, Lancet 338:1345-13491991., , 1991

Aspirin:What Dose? Editorial
Lancet 1:592-593, , 1986

Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients with Atrial Cardiopathy, The ARCADIA Randomized Clinical Trial
JAMA 331:573-581, Kamel,H.,et al, 2024

Cortical Superficial Siderosis and Transient Focal Neurological Episode Preceding Lobar Hemorrhage in Cerebral Amyloid Angiopathy
Stroke 54:e48-e51, Therdorou,A.,et al, 2023

Antithrombotic Therapy in Patients with Cerebral Microbleeds or Cortical Siderosis, Is This Contraindicated?
Neurol 100:551-552, Schneck,M.J., &Biller,J., 2023

Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion
NEJM 388:2025-2095, Zi,W.,et al, 2023

Antiplatelet Therapy or Not for Asymptomatic/Incidental Lacunar Infarction
Stroke 54:1954-1959, Bilski.A.,et al, 2023

Perioperative Management of Anticoagulant and Antiplatelet Therapy
NEJM Evid doi:10.1056/EVIDna2200322, Douketis,J.D. & Spyropoulos,A.C., 2023

Perioperative Acute Ischemic Stroke in Patients with Atrial Fibrillation
Ann Neurol 94:321-329, Shu,L.et al, 2023

Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke
Stroke 54:2981-2989, Yoo,J.,et al, 2023

Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke
NEJM 389:2413-2424, 2478, Gao,Y.et al, 2023

Bleeding Risk of Dual Antiplatelet Therapy after Minor Stroke or Transient Ischemic Attack
Ann Neurol 91:380-388, Wang, A.,et al, 2022

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory
Neurol 98:486-498, Turan, T.N.,et al, 2022

Oral Antiplatelet Therapy for Acute Ischemic Stroke
Stroke 53:e453-e454, Minhas, J.S.,et al, 2022

Updates on Sturge-Weber Syndrome
Stroke 53:3769-3779, Yeom,S.E.&Comi,A.M., 2022

Cerebral Microbleeds
Stroke 52:2347-2355, Graff-Radford, J.,et al, 2021

Use of Dual Antiplatelet Therapy Following Ischemic Stroke
Stroke 51:e78-e80, Dong, J.,et al, 2020

Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events
Stroke 51:1464-1469, Murthy, S.B.,et al, 2020

Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke
Stroke 51:1616-1619, Beharry, J.,et al, 2020

Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020

Transient Ischemic Attack
NEJM 382:1933-1941, Amarenco, P., 2020

Antiplatelet Treatment to Prevent Early Recurrent Stroke
NEJM 383:276-278, Rothwell, P.M., 2020

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
NEJM 380:1906-1917, Diener, H.C.,et al, 2019

Antiplatelet Therapy vs Anticoagulation Therapy in Cervical Artery Dissection
JAMA Neurol 76:657-664, Markus, H.S.,et al, 2019

Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared with Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke
JAMA Neurol 76:774-782, Tillman, H.,et al, 2019

Management of Anticoagulants in Patients Undergoing Endoscopic Procedure
www.UptoDate.com, Dec, Kamath, P.S., 2018

Antiplatelet and Anticoagulant Agents for Secondary Prevention of Thromboembolic Events in People with Antiphospholipid Syndrome
Stroke 49:e41-e42, Bala, M.M.,et al, 2018

Diagnosis and Management of Active Intracranial Atherosclerotic Disease
Stroke 49:e221-e223, Narwal, P.,et al, 2018



Showing articles 0 to 50 of 487 Next >>